Table 1.
Species | Inducer | Tissue/cell | Time/stage | Mitochondrial assessments | Refs. |
---|---|---|---|---|---|
Human | N.A | PBMCs | With shock | Oxygen consumption reduced; ATP synthase activity declined | [15] |
Human | N.A | PBMCs | Early stages without shock or MOF | CI, CIII, and CIV activity decreased; ΔΨm reduced; Oxygen consumption reduced; Circulating free mtDNA in plasma increased | [16] |
Human | N.A | Platelet | Severe sepsis or septic shock | Mitochondrial NADH, CI, CI & III, and CIV, succinate dehydrogenase (SDH) activity decreased | [17] |
Human | N.A | Leg and serratus anterior muscle | With MOF and requiring mechanical ventilation |
Leg muscle: CI activity unchanged; CIV activity and ATP reduced; morphology unchanged Serratus anterior muscle: CI activity decreased; CIV activity, ATP, and morphology unchanged The observed changes probably because of reduced mitochondrial mass |
[28] |
Human | N.A | Vastus lateralis muscle | With MOF | Structure swollen or damaged; Respiratory protein subunits and transcripts reduced | [19] |
Human | N.A | Heart | Post-mortem | Mitochondrial cristae impaired | [20] |
Mouse | LPS | Heart | 24 h | Mitochondrial number and volume reduced; Mitochondrial displayed internal vesicles, disrupted structure, and loss of cristae; expression of OXPHOS genes decreased | [29] |
Mouse | LPS | Kidney | 18 h | Mitochondrial swollen and cristae reduced; Cytochrome c oxidase protein level and activity decreased; Mitochondrial gene expression was suppressed | [30] |
Mouse | LPS | Liver | 0–48 h | mtDNA levels/integrity, complex I activity, and ATP level reduced; mtROS increased | [31] |
Mouse | LPS | Leg muscle | 28 days | Mitochondrial respiration reduced; CV activity was reduced; Mitochondrial fission increased; | [32] |
Mouse | CLP | Brain | 24 h | Oxidative phosphorylation uncoupled; ΔΨm dissipated; CIV activity reduced; CI-III activity unchanged | [33] |
Mouse | CLP | Heart | 12 h | mtDNA copy number reduced; mitochondrial respiration reduced; ATP level declined; mitochondrial biogenesis marker PGC1β reduced; mitochondrial Ca2+ uptake capacity declined | [34] |
Mouse | CLP | Kidney | 6–36 h | ROS increased; CI, CII & CIII activity and ATP decreased; CIV activity unchanged | [35] |
Rat | LPS | Heart | 0–24 h | Mitochondria displayed structural abnormalities; CI, II, and IV activities reduced; ATP synthesis decreased | [36] |
Rat | LPS | Liver | 2 h | Mitochondrial oxygen consumption reduced despite the total oxygen consumption unchanged; mitochondria became swollen and pale, with indistinct cristae and disrupted membranes; ATP/ADP ratio unchanged | [37] |
Rat | S. pneumoniae | Heart | 24 h | ROS increased; mtDNA damaged; mitochondrial membrane disrupted; CI, II-III, IV and V activity reduced | [38] |
Cat | LPS | Liver | 4 h | Respiratory activity was impaired; mitochondrial ultrastructural injured (swollen and membrane disruption) | [39] |
Baboon | E. coli | Heart | 72 h or after death | CI, and II activities reduced; CIII was less affected | [25] |
MOF multi-organ failure. CI, II, III, IV, V: mitochondrial respiratory complex I, II, III, IV, V. ΔΨm: mitochondrial membrane potential